These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer. Rossi A; Riva A; Bonadonna G Cancer Chemother Rep; 1975; 59(6):1161-2. PubMed ID: 769958 [No Abstract] [Full Text] [Related]
6. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)]. Zeller WJ; Berger M Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646 [TBL] [Abstract][Full Text] [Related]
7. Adriamycin and cyclophosphamide versus hydroxyurea in advanced prostatic cancer. A randomized Southwest Oncology Group study. Stephens RL; Vaughn C; Lane M; Costanzi J; O'Bryan R; Balcerzak SP; Levin H; Frank J; Coltman CA Cancer; 1984 Feb; 53(3):406-10. PubMed ID: 6362815 [TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients. Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895 [TBL] [Abstract][Full Text] [Related]
9. Treatment of small cell carcinoma of the lung using methyl-CCNU (NSC-95441) combined with cyclophosphamide (NSC-26271) and vincristine (NSC-67574) in a 3-week schedule. Taylor SG; Donavan MA; Sponzo RW; Cunningham TJ; Horton J Cancer Chemother Rep; 1975; 59(6):1127-30. PubMed ID: 769951 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma. Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102 [No Abstract] [Full Text] [Related]
16. Oral cyclophosphamide and oral hydroxyurea in the treatment of hormone refractory prostate cancer in rats. Naik H; Lehr J; Akhtar A; Pienta K Anticancer Res; 1994; 14(6B):2681-4. PubMed ID: 7872701 [TBL] [Abstract][Full Text] [Related]
17. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. Walker MD; Green SB; Byar DP; Alexander E; Batzdorf U; Brooks WH; Hunt WE; MacCarty CS; Mahaley MS; Mealey J; Owens G; Ransohoff J; Robertson JT; Shapiro WR; Smith KR; Wilson CB; Strike TA N Engl J Med; 1980 Dec; 303(23):1323-9. PubMed ID: 7001230 [TBL] [Abstract][Full Text] [Related]
18. Phase I trial of combination methotrexate and methyl-CCNU in patients with advanced neoplastic diseases. Lehane DE; Lane M; Tranum B; Costanzi J; Padilla F Cancer Treat Rep; 1977 Aug; 61(5):889-91. PubMed ID: 329982 [No Abstract] [Full Text] [Related]
19. [Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU]. Fleischer I; Wainstein R; Jovtis S; Colombato LO Acta Gastroenterol Latinoam; 1978; 8(3):191-3. PubMed ID: 747086 [TBL] [Abstract][Full Text] [Related]
20. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer. Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]